These forward-looking statements address activities, events, conditions, or developments that we currently expect or anticipate may occur in the future, and include, but may not be limited to, discussions and statements regarding revenue guidance, product development, timing of plant construction completion, testing and certification, impact of the government policies and regulations, regulatory approval process, production capacity, capital expense estimate, future operations, investment portfolio management, and future strategies. Forward-looking statements can be identified by such terminology as "believe," "expect," "plans," "strategy," "potential", "prospects," "forecast," "estimate," "project," "anticipate," "aim," "will" or "would", "may" or "might", and words, phrases, expressions, and usages of similar meaning or substance or the negative of such words, phrases, expressions and usages.
Forward-looking statements are based on management's current assumptions,
beliefs, expectations, and projections, in light of the information currently
available to it, and actual results, performances, or achievements could
differ materially from those implied or expressed by the forward-looking
statements. Among the factors that could cause 3SBio's actual results to
differ from what the Company currently anticipates may include competition
from other domestic and foreign pharmaceutical companies; the expected market
growth for pharmaceutical products in China; market acce
|SOURCE 3SBio Inc.|
Copyright©2010 PR Newswire.
All rights reserved